MCM
COLL icon

Matarin Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Matarin Capital Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-28,270
Closed -$485K – 270
2018
Q4 		$485K Buy
+28,270
New +$484K 0.04% 239

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Matarin Capital Management's COLL Position: Q1 2019 in Review

Matarin Capital Management sold out of Collegium Pharmaceutical (COLL) in Q1 2019, closing a stake of 28,270 shares — an estimated $485K sold.

Matarin Capital Management first reported a position in COLL in Q4 2018 and held it in 1 quarter. The position peaked at $485K in Q4 2018. 145 funds tracked by Wall St. Rank hold COLL as of Q1 2019.

  • Matarin Capital Management reported no remaining Collegium Pharmaceutical position as of Q1 2019 after selling out during the quarter.
  • Matarin Capital Management sold 28,270 Collegium Pharmaceutical shares in Q1 2019, an estimated $485K.
  • Matarin Capital Management first reported a position in Collegium Pharmaceutical in Q4 2018 and held it in 1 quarter.
  • Matarin Capital Management's Collegium Pharmaceutical position peaked at $485K in Q4 2018.
  • 145 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2019.

Based on Matarin Capital Management's 13F filing for Q1 2019, filed 24 Apr 2019.